B
ANTH

Bailard’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Bailard’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-22,000
Closed -$708K – 257
2013
Q3 		$708K Sell
22,000
-8,232
-27% -$265K 0.13% 126
2013
Q2 		$896K Buy
+30,232
New +$896K 0.16% 112